Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis

Tumoral necrosis factor α plays a central role in both the inflammatory response and that of the immune system. Thus, its blockade with the so-called anti-TNF agents (infliximab, etanercept, adalimumab, certolizumab pegol, and golimumab) has turned into the most important tool in the management of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Cano, Daniel, Callejas-Rubio, José Luis, Ruiz-Villaverde, Ricardo, Ríos-Fernández, Raquel, Ortego-Centeno, Norberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747407/
https://www.ncbi.nlm.nih.gov/pubmed/23983404
http://dx.doi.org/10.1155/2013/286857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747407/
https://www.ncbi.nlm.nih.gov/pubmed/23983404
http://dx.doi.org/10.1155/2013/286857

Ejemplares similares